Bio-Path Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BPTH and buy or sell other stocks, ETFs, and their options commission-free!About BPTH
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003.
CEOPeter H. Nielsen
CEOPeter H. Nielsen
Employees10
Employees10
HeadquartersBellaire, Texas
HeadquartersBellaire, Texas
Founded2007
Founded2007
Employees10
Employees10
BPTH Key Statistics
Market cap46.99M
Market cap46.99M
Price-Earnings ratio-3.50
Price-Earnings ratio-3.50
Dividend yield—
Dividend yield—
Average volume203.55K
Average volume203.55K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.24
52 Week high$2.24
52 Week low$0.32
52 Week low$0.32
Stock Snapshot
The current Bio-Path Holdings(BPTH) stock price is $3.78, with a market capitalization of 46.99M. The stock trades at a price-to-earnings (P/E) ratio of -3.50.
During the trading day, Bio-Path Holdings(BPTH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Bio-Path Holdings(BPTH) stock has reached 0, versus its average volume of 203.55K.
Over the past 52 weeks, Bio-Path Holdings(BPTH) stock has traded between a high of $2.24 and a low of $0.32.
Over the past 52 weeks, Bio-Path Holdings(BPTH) stock has traded between a high of $2.24 and a low of $0.32.
People also own
Based on the portfolios of people who own BPTH. This list is generated using Robinhood data, and it’s not a recommendation.